TECVAYLI®, a bispecific antibody, is the first treatment of its kind designed to fight multiple myeloma
TECVAYLI® works by helping your immune system locate the multiple myeloma cells in your body.
One side of TECVAYLI® binds to proteins called BCMA, which are found on multiple myeloma cells (as well as some healthy cells). The other side binds to proteins called CD3, which are found on your T-cells.
In doing so, TECVAYLI® is able to activate the T-cells in your immune system to destroy the multiple myeloma cells in the rest of your body.
TECVAYLI® is a kind of medicine called a bispecific antibody, which means it attaches to 2 different cells.